Actos Manufacturer May Have Covered Up Diabetes Drug Side Effects

By | Dangerous & Defective Drugs

A medical reviewer from Takeda Pharmaceutical Company, manufacturer of diabetes drug Actos, is blowing the whistle on her former employer, claiming that it covered up known cases of congestive heart failure related to Actos use. Specifically, she alleges that the company did not consider “non-hospitalized or non-fatal” cases of congestive heart failure between 2007 and 2010 as “serious” and report the side effects to the FDA. The U.S. Food and Drug Administration (FDA) regulates the production of dangerous drugs and requires negative side effects be self-reported to the agency via its Adverse Event Reporting System. The whistleblower claims that Takeda’s…

Read More

Long-term Actos Use Linked to Bladder Cancer

By | Dangerous & Defective Drugs

In June 2011, the Food and Drug Administration (FDA) warned that the use of Actos over an extended period of time may cause bladder cancer. Use of the dangerous & defective drug was discontinued in France and Germany, but not in the United States. The warning followed a 2010 study that revealed an increased likelihood of developing bladder cancer in those who had taken Actos for a year or more. With the warning, Actos joins a growing list of known dangerous & defective drugs once thought to help patients, but later found to harm them. Actos was intended to help people with…

Read More